Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Van Ameringen, M. A. Articles by Swinson, R. P. Search for Related Content PubMed Citation Articles by Van Ameringen, M. A. Articles by Swinson, R. P. Phobic Disorders Antidepressants

Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study

OBJECTIVE: The authors evaluated the efficacy, safety, and tolerability of sertraline, a selective serotonin reuptake inhibitor, in the treatment of generalized social phobia. METHOD: Adult outpatients with generalized social phobia (N=204) from 10 Canadian centers were randomly assigned to receive sertraline or placebo in a 2:1 ratio for a 20-week double-blind study following a 1-week, single-blind, placebo run-in. The initial dose of sertraline was 50 mg/day with increases of 50 mg/day every 3 weeks permitted after the fourth week of treatment (dosing was flexible up to a maximum of 200 mg/day). Primary efficacy assessments were the percentage of patients rated much or very much improved on the Clinical Global Impression (CGI) improvement item and the mean changes from baseline to study endpoint in total score on the social phobia subscale of the Marks Fear Questionnaire and total score on the Brief Social Phobia Scale. RESULTS: In intent-to-treat endpoint analyses of 203 of the patients, significantly more of the 134 patients given sertraline (N=71 [53%]) than of the 69 patients receiving placebo (N=20 [29%]) were considered responders according to their CGI improvement scores at the end of treatment. The mean reductions in the social phobia subscale of the Marks Fear Questionnaire and in the total score on the Brief Social Phobia Scale were 32.6% and 34.3% in the sertraline group and 10.8% and 18.6% in the placebo group, respectively. Analysis of covariance showed superiority of sertraline over placebo on all primary and secondary efficacy measures. Sertraline was well tolerated: 103 (76%) of the 135 sertraline-treated patients and 54 (78%) of the 69 placebo-treated patients completed the study. CONCLUSIONS: Sertraline is an effective treatment for patients with generalized social phobia.

This article has been cited by other articles:

				D. W. Hedges, B. L. Brown, D. A. Shwalb, K. Godfrey, and A. M. Larcher The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials J Psychopharmacol, January 1, 2007; 21(1): 102 - 111. [Abstract] [PDF]

				S. Kasper, D. J. Stein, H. Loft, and R. Nil Escitalopram in the treatment of social anxiety disorder: Randomised, placebo-controlled, flexible-dosage study The British Journal of Psychiatry, March 1, 2005; 186(3): 222 - 226. [Abstract] [Full Text] [PDF]

				M. R. Liebowitz, A. J. Gelenberg, and D. Munjack Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder Arch Gen Psychiatry, February 1, 2005; 62(2): 190 - 198. [Abstract] [Full Text] [PDF]

				J. R. T. Davidson, E. B. Foa, J. D. Huppert, F. J. Keefe, M. E. Franklin, J. S. Compton, N. Zhao, K. M. Connor, T. R. Lynch, and K. M. Gadde Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placebo in Generalized Social Phobia Arch Gen Psychiatry, October 1, 2004; 61(10): 1005 - 1013. [Abstract] [Full Text] [PDF]

				C. Allgulander, A. A. Dahl, C. Austin, P. L.P. Morris, J. A. Sogaard, R. Fayyad, S. P. Kutcher, and C. M. Clary Efficacy of Sertraline in a 12-Week Trial for Generalized Anxiety Disorder Am J Psychiatry, September 1, 2004; 161(9): 1642 - 1649. [Abstract] [Full Text] [PDF]

				D. J. Stein, M. Versiani, T. Hair, and R. Kumar Efficacy of Paroxetine for Relapse Prevention in Social Anxiety Disorder: A 24-Week Study Arch Gen Psychiatry, December 1, 2002; 59(12): 1111 - 1118. [Abstract] [Full Text] [PDF]

				M. B. Stein, J. Sareen, S. Hami, and J. Chao Pindolol Potentiation of Paroxetine for Generalized Social Phobia: A Double-Blind, Placebo-Controlled, Crossover Study Am J Psychiatry, October 1, 2001; 158(10): 1725 - 1727. [Abstract] [Full Text] [PDF]

				G. Pieters Sertraline was effective and well tolerated for generalised social phobia Evid. Based Ment. Health, August 1, 2001; 4(3): 91 - 91. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us